Form 4 for LNAI Lunai Bioworks Inc.
Accepted 2023-11-14 00:00:00 ET · period of report 2023-10-23 · accession 0001731122-23-002098 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-11-14 | 2023-10-23 | LNAI | Miller Avram | Dir | A - Grant | $0.00 | +1.00M | 1.00M | New | $0 |
| D | 2023-11-14 | 2023-10-23 | LNAI | Miller Avram | Dir | A - Grant | $0.00 | +27.1K | 27.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-23 | A | A | 1,000,000 | $0.00 | 1,000,000 | D | — | — | (F1) On October 11, 2023, the Reporting Person entered into an Advisory Agreement, pursuant to which the Issuer agreed to issue Mr. Miller 1,000,000 shares of restricted stock, 166,667 of which will vest in 2024, 444,444 will vest in 2025, and 388,889 will vest in 2026, subject to Mr. Miller's continued service through each applicable vesting date. |
| 2 | Derivative | Option to purchase shares of common stock | 2023-10-23 | A | A | 27,147 | $0.00 | 27,147 | D | $2.76 · 2024-10-11 to 2033-10-11 | 27,147 Common stock |